LEFLUNOMIDE β LUPIN, approved 2024-12-17 (ANDA211863).
239,393 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System β they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.